Skip to main content

CCTG Connection



Published:
Category: Group updates
IND.244  CHU de Québec –  Hôpital L’Enfant-Jésus

The Investigational New Drug Program Team Award was presented to the IND.244 team at CHU de Québec – Hôpital L’Enfant-Jésus for their work activating and recruiting patients to this trial. Awarded at the CCTG Spring Meeting to a non-MD team of clinical research associates, nurses, pharmacists and others who participated in a CCTG IND clinical trial to acknowledge their efforts and dedication to the success of clinical trials. 

Read More

Published:
Category: Group updates
Dr. Rachel Glicksman Princess Margaret Cancer Centre

The Ralph Meyer Phase III Program Young Investigator Award has been awarded to Dr. Rachel Glicksman from Princess Margaret Cancer Centre recognizing her active participation and enrollment activities as a young investigation in CCTG trials. This award is presented to individuals who have made significant contributions to the phase III program research projects.

Read More

Published:
Category: Group updates
ALC.7 Team Arthur J.E. Child Comprehensive Cancer Centre
At the 2025 annual Spring Meeting of Participants the group presented the Phase III Program Team Award for an intergroup led trial to the ALC.7 team from Arthur J.E.
Read More

Published:
Category: News
CRA Lunch and Learn training program

CCTG will be holding the next CRA Lunch and Learn on Wednesday June 11th, 2025, at 12 pm ET. Session 5 will cover the topic of Understanding the Centre Performance Index (CPI)

 

Read More

Published:
Category: Office of the Director
Spring Meeting 2025: Record-Breaking Attendance and Inspiring Achievements

The 2025 CCTG Spring Meeting of Participants wrapped up with a record 941 members attending. This dynamic gathering helped shape our future research agenda and celebrated many achievements across our network.

Read More



Published:
Category: Publications
Publication: EN7 conference abstract
An EN7 conference abstract presented at the United States and Canadian Academy of Pathology Annual Meeting 22-27 March, 2025 in Boston and subsequently published in Laboratory Investigation. 1006 Identifying H&E-based Immune Patterns in Endometrial Carcinoma and Their Association with Clinicopathologic Variables, Tumor Mutational Landscape, and Survival presented at the United States and Canadian Academy of Pathology Annual Meeting 22-27 March, 2025 in Boston and subsequently published in Laboratory Investigation. Read More

Published:
Category: Publications
ASCO GU poster presentations
Congratulations to the researchers who had poster presentations at the ASCO Genitourinary Cancer Symposium in San Francisco, February 13-15, 2025.
 
PRC4 - Ryan CJ, Kim H, Morris MJ, Alyamani M, Diaz R, Beltran H, Armstrong AJ, Sharifi N, Halabi S. Racial differences in organic anion transport proteins (OATP) and outcome in castration resistant prostate cancer treated with AR pathway inhibitors in Alliance A031201: A phase III trial. ASCO Genitourinary Cancer Symposium.
Read More

Published:
Category: Publications
Publication: EORTC validation study
A meta-analysis completed by the EORTC using data from the following CCTG trials: BR20, BR21, BR24, BR25, BR26, BR29, CE6, CO17, CO20, C023, IND210, MA21, MA31, MY10, OV16, OV21, PA3, SC19, SC20. Read More